Alfred P. SPADA

Person

Carlsbad, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Caspase inhibitors and methods of use thereof
- Patent number 12,071,412
- Issue date Aug 27, 2024
- NOBO Medicine Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Caspase inhibitors and methods of use thereof
- Patent number 11,597,703
- Issue date Mar 7, 2023
- Histogen, Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,...
- Patent number 11,447,497
- Issue date Sep 20, 2022
- Histogen, Inc.
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted oxoazaheterocyclyl compounds
- Patent number 7,612,075
- Issue date Nov 3, 2009
- Aventis Pharmaceuticals Inc.
- William R. Ewing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 7,550,597
- Issue date Jun 23, 2009
- Aventis Pharmaceuticals, Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,852,712
- Issue date Feb 8, 2005
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,846,815
- Issue date Jan 25, 2005
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,821,962
- Issue date Nov 23, 2004
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,696,434
- Issue date Feb 24, 2004
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...
- Patent number 6,645,969
- Issue date Nov 11, 2003
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having antihypertensive, cardioprotective anti-ischemic a...
- Patent number 6,559,313
- Issue date May 6, 2003
- Aventis Pharma Deutschland GmbH
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,528,526
- Issue date Mar 4, 2003
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,524,347
- Issue date Feb 25, 2003
- Avantis Pharmaceuticals Inc.
- Michael. R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,482,834
- Issue date Nov 19, 2002
- Aventis Pharmaceuticals Inc.
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having antihypertensive, cardioprotective, anti-ischemic...
- Patent number 6,376,472
- Issue date Apr 23, 2002
- Aventis Pharmaceuticals, Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...
- Patent number RE37650
- Issue date Apr 9, 2002
- Aventis Pharmacetical Products, Inc.
- Michael R. Myers
- 514 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Substituted N-[(aminoiminomethyl or aminomethyl)phenyl&#x00...
- Patent number 6,323,227
- Issue date Nov 27, 2001
- Aventis Pharmaceuticals Products Inc.
- Scott I. Klein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,245,760
- Issue date Jun 12, 2001
- Aventis Pharmaceuticals Products, Inc
- Wei He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,180,632
- Issue date Jan 30, 2001
- Aventis Pharmaceuticals Products Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Patent number 6,159,978
- Issue date Dec 12, 2000
- Aventis Pharmaceuticals Product, Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted intermediate compounds for the preparation of n-[(amino...
- Patent number 6,140,504
- Issue date Oct 31, 2000
- Aventis Pharmaceuticals Products Inc.
- Scott I. Klein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
- Patent number 6,080,767
- Issue date Jun 27, 2000
- Aventis Pharmaceuticals Products Inc.
- Scott I. Klein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit E...
- Patent number 6,057,320
- Issue date May 2, 2000
- Aventis Pharmaceuticals Products Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azahete...
- Patent number 6,034,093
- Issue date Mar 7, 2000
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- William R. Ewing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfiny...
- Patent number 5,958,918
- Issue date Sep 28, 1999
- Rhone-Poulenc Rorer Pharmaceuticals Inc.
- William R. Ewing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...
- Patent number RE36256
- Issue date Jul 20, 1999
- Rhone-Poulenc Rorer Pharmaceuticals, Inc.
- Alfred P. Spada
- 514 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...
- Patent number 5,795,889
- Issue date Aug 18, 1998
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having antihypertensive, cardioprotective, anti-ischemic...
- Patent number 5,736,554
- Issue date Apr 7, 1998
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted sulfonic acid n-�(aminoiminomethyl)phenylalkyl!-azahete...
- Patent number 5,731,315
- Issue date Mar 24, 1998
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- William R. Ewing
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds h...
- Patent number 5,721,237
- Issue date Feb 24, 1998
- Rhone Poulenc Rorer Pharmaceuticals Inc.
- Michael R. Myers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CASPASE INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20230250067
- Publication date Aug 10, 2023
- Histogen, Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(S)-3-(2-(4-(BENZYL)-3-OXOPIPERAZIN-1-YL)ACETAMIDO)-4-OXO-5-(2,3,5,...
- Publication number 20210277014
- Publication date Sep 9, 2021
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CASPASE INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20200283396
- Publication date Sep 10, 2020
- Conatus Pharmaceuticals Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING CASPASE INHIBITORS IN TREATMENT OF LIVER DISEASE
- Publication number 20190022043
- Publication date Jan 24, 2019
- Conatus Pharmaceuticals Inc.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF THE COMPLICATIONS OF CHRONIC LIVER DISEASE WITH CASPAS...
- Publication number 20170100448
- Publication date Apr 13, 2017
- Conatus Pharmaceuticals, Inc.
- Alfred P. SPADA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF THE COMPLICATIONS OF CHRONIC LIVER DISEASE
- Publication number 20160213736
- Publication date Jul 28, 2016
- Conatus Pharmaceuticals, Inc.
- Alfred P. SPADA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR THE TREATMENT OF LIVER DISEASES
- Publication number 20110212056
- Publication date Sep 1, 2011
- CONATUS PHARMACEUTICALS, INC.
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tetrapeptide analogs
- Publication number 20100190688
- Publication date Jul 29, 2010
- Bin Chao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for the treatment of liver diseases
- Publication number 20080207569
- Publication date Aug 28, 2008
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination therapy for the treatment of liver diseases
- Publication number 20080207605
- Publication date Aug 28, 2008
- Alfred P. Spada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-vascular and anti-proliferation methods, therapies, and combin...
- Publication number 20070197538
- Publication date Aug 23, 2007
- Mark Nesbit
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20050182054
- Publication date Aug 18, 2005
- Aventis Pharmaceuticals Inc.
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted oxoazaheterocyclyl compounds
- Publication number 20040102450
- Publication date May 27, 2004
- Aventis Pharmaceuticals Inc.
- William R. Ewing
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...
- Publication number 20040014774
- Publication date Jan 22, 2004
- Michael R. Myers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating insulin resistance syndrome and diabetes
- Publication number 20030176390
- Publication date Sep 18, 2003
- Andreas Herling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20030144284
- Publication date Jul 31, 2003
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20030139399
- Publication date Jul 24, 2003
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20030139400
- Publication date Jul 24, 2003
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20030130285
- Publication date Jul 10, 2003
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds having antihypertensive, cardioprotective anti-ischemic a...
- Publication number 20020099030
- Publication date Jul 25, 2002
- Michael R. Myers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline and quinoxaline compounds which inhibit platelet-derived...
- Publication number 20010023250
- Publication date Sep 20, 2001
- Alfred P. Spada
- C07 - ORGANIC CHEMISTRY

Alfred P. SPADA

Person

Patents Grantslast 30 patents

Caspase inhibitors and methods of use thereof

Caspase inhibitors and methods of use thereof

(S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,...

Substituted oxoazaheterocyclyl compounds

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...

Compounds having antihypertensive, cardioprotective anti-ischemic a...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Compounds having antihypertensive, cardioprotective, anti-ischemic...

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...

Substituted N-&#x0005B;(aminoiminomethyl or aminomethyl)phenyl&#x00...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Substituted intermediate compounds for the preparation of n-[(amino...

Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides

Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit E...

Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azahete...

Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfiny...

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit...

Compounds having antihypertensive, cardioprotective, anti-ischemic...

Substituted sulfonic acid n-�(aminoiminomethyl)phenylalkyl!-azahete...

Protein tyrosine kinase aryl and heteroaryl quinazoline compounds h...

Patents Applicationslast 30 patents

CASPASE INHIBITORS AND METHODS OF USE THEREOF

(S)-3-(2-(4-(BENZYL)-3-OXOPIPERAZIN-1-YL)ACETAMIDO)-4-OXO-5-(2,3,5,...

CASPASE INHIBITORS AND METHODS OF USE THEREOF

METHODS OF USING CASPASE INHIBITORS IN TREATMENT OF LIVER DISEASE

TREATMENT OF THE COMPLICATIONS OF CHRONIC LIVER DISEASE WITH CASPAS...

TREATMENT OF THE COMPLICATIONS OF CHRONIC LIVER DISEASE

COMBINATION THERAPY FOR THE TREATMENT OF LIVER DISEASES

Tetrapeptide analogs

Methods for the treatment of liver diseases

Combination therapy for the treatment of liver diseases

Anti-vascular and anti-proliferation methods, therapies, and combin...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Substituted oxoazaheterocyclyl compounds

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R rece...

Methods of treating insulin resistance syndrome and diabetes

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Compounds having antihypertensive, cardioprotective anti-ischemic a...

Quinoline and quinoxaline compounds which inhibit platelet-derived...

Substituted N-[(aminoiminomethyl or aminomethyl)phenyl&#x00...